NOVN — Novartis Share Price

As of Today at 03:22 UTC, shares in Novartis are trading at CH₣118.70. This share price information is delayed by 15 minutes.

Shares in Novartis last closed at CH₣118.70 and the price had moved by +21% over the past 365 days. In terms of relative price strength the Novartis share price has outperformed the FTSE Global All Cap Index by +7.72% over the past year.

The overall consensus recommendation for Novartis is Hold. You can view the full broker recommendation list by unlocking its StockReport.

The Novartis dividend yield is 3.06% based on the trailing twelve month period.

Last year, Novartis paid a total dividend of $4.67, and it currently has a trailing dividend yield of 3.06%. We do not have any data on when Novartis is to next pay dividends.

We do not have data on when Novartis is to next pay dividends.  The historic dividend yield on Novartis shares is currently 3.06%.

To buy shares in Novartis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of CH₣118.70, shares in Novartis had a market capitalisation of CH₣227.76bn.

Here are the trading details for Novartis: 

• Country of listing: Switzerland
• Exchange: SWX
• Ticker Symbol: NOVN

Based on an overall assessment of its quality, value and momentum Novartis is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in Novartis is CH₣114.12.  That is 3.86% below the last closing price of CH₣118.70.

Analysts covering Novartis currently have a consensus Earnings Per Share (EPS) forecast of $9.04 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like Novartis. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +12.54%.

As of the last closing price of CH₣118.70, shares in Novartis were trading +17.53% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The Novartis PE ratio based on its reported earnings over the past 12 months is 16.75. The shares last closed at CH₣118.70. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Novartis' management team is headed by: 

• Joerg Reinhardt - NEC
• Vasant Narasimhan - CEO
• Enrico Vanni - NVC
• Harry Kirsch - CFO
• Robert Kowalski - CHO
• Steffen Lang - CTO
• Klaus Moosmayer - CCO
• James Bradner - EXB
• Karen Hale - EXB
• Richard Saynor - EXB
• Susanne Schaffert - EXB
• John Tsai - EXB
• Marie-France Tschudin - EXB
• Robert Weltevreden - EXB
• Charlotte Pamer- Wieser - SEC
• Nancy Andrews - NID
• Ton Buechner - NID
• Patrice Bula - NID
• Elizabeth Doherty - NID
• Ann Fudge - NID
• Bridgette Heller - NID
• Simon Moroney - NID
• Charles Sawyers - NID
• Frans van Houten - NID
• Andreas von Planta - NID
• William Winters - NID